From: Three-day dendritic cells for vaccine development: Antigen uptake, processing and presentation
2d iDC | 6d iDC | 3d mDC | 7d mDC | |
---|---|---|---|---|
Donor 1 | ||||
Yield* | n.d.+ | n.d.+ | 8% | 4% |
Purity # | n.d.+ | n.d.+ | 39% | 34% |
Viability $ | n.d.+ | n.d.+ | 94% | 78% |
Donor 3 & | ||||
Yield* | 12%§ | 6%§ | 18% | 9% |
Purity# | 57% | 58% | 60% | 70% |
Viability$ | 93% | 84% | 95% | 86% |
Donor 4 & | ||||
Yield* | n.d.+ | n.d.+ | 4% | 3% |
Purity# | 32% | 30% | 42% | 60% |
Viability$ | 85% | 76% | 86% | 81% |